James Peter Lapolla MD FACOG, FACS, MBA
Gynecologic Cancer
Women's Cancer Associates
Join to View Full Profile
600 8th St SSte BSaint Petersburg, FL 33701
Phone+1 727-821-9688
Fax+1 727-821-9678
Dr. Lapolla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Obstetrics and Gynecology, 1981 - 1983- University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gynecologic Oncology, 1981 - 1983
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Obstetrics and Gynecology, 1976 - 1981
Los Angeles County-Harbor-UCLA Medical CenterInternship, Internal Medicine, 1975 - 1976
University of Illinois College of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1977 - Present
FL State Medical License 1986 - 2026
KS State Medical License 2021 - 2022
MA State Medical License 2021 - 2021
OH State Medical License 1962 - 2014
IA State Medical License 1983 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsMeasurement of Phospholipids May Improve Diagnostic Accuracy in Ovarian CancerLian Shan, Y. Ann Chen, Lorelei Davis, Gang Han, Weiwei Zhu
Plos One. 2012-10-17 - 22 citationsA phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapyRobert M. Wenham, James P. LaPolla, Hui-Yi Lin, Sachin M. Apte, Johnathan M. Lancaster
Gynecologic Oncology. 2011-03-01 - 3 citationsSociety of Gynecologic Oncologists Position Paper: Breast Cancer CareJames W. Orr, Joseph L. Kelley, Don S. Dizon, Pedro F. Escobar, Evelyn L. Fleming
Gynecologic Oncology. 2008-07-01
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Fellow
- Fellow
- Fellow
- Member
- Member
Other Languages
- Farsi, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
